Providers WA

12/29/21 Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir

Requested actions Be aware that the community testing site in Whatcom has decreased capacity due to staffing and weather conditions. Be aware, Centers for Disease Control and Prevention (CDC) issued new isolation and quarantine (I&Q) guidance for healthcare workers (HCWs). The guidance is complex and varies based on vaccination status, level of exposure and level 12/29/21 Health Advisory: COVID-19 Updates for Providers – New I&Q Guidance, FDA grants EUA to Molnupiravir

12/22/21 Health Advisory: Paxlovid granted EUA and Testing before gathering

COVID-19 Updates for Providers Requested actions Be aware, Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first oral antiviral treatment for COVID-19, Pfizer’s Paxlovid. The EUA comes after research showed Paxlovid was nearly 90% effective at preventing hospitalization and death in people 12 years or older at high risk of severe 12/22/21 Health Advisory: Paxlovid granted EUA and Testing before gathering

12/17/2021 Health Advisory: Updated J&J Vaccine Recommendations

Syringe drawing from a vial

Requested actions Be aware, on Dec. 16, Centers for Disease Control and Prevention (CDC) recommended mRNA COVID-19 vaccines (Pfizer or Moderna) over Johnson & Johnson (J&J) COVID-19 vaccine for all people 18 years or older. The recommendation is based on the increased risk of thrombosis with thrombocytopenia syndrome (TTS) after getting J&J COVID-19 vaccine. Be 12/17/2021 Health Advisory: Updated J&J Vaccine Recommendations

12/13/21: Health Advisory: COVID-19 Updates for Providers

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech 12/13/21: Health Advisory: COVID-19 Updates for Providers

12/03/21 Health Advisory: COVID-19 Updates for Providers

Scientists in lab using microscope

COVID-19 Updates for Providers Requested Actions Be aware, Centers for Disease Control and Prevention (CDC) issued a health advisory warning of COVID-19 variant of concern Omicron (B.1.1.529). Cases have been detected in multiple states. Omicron has not yet been detected in Whatcom County; however, we are tracking its impact nationally and globally. This new variant has 12/03/21 Health Advisory: COVID-19 Updates for Providers

10/23/21 Health Advisory: COVID-19 Updates for Providers

syringe in a vial

Requested actions Be aware, on October 22, the Centers for Disease Control and Prevention (CDC) recommended a single booster dose of Moderna SARS-CoV-2 vaccine to certain high risk populations at least 6 months after their primary series under the Food and Drug Administration’s (FDA) expanded emergency use authorization (EUA). We are awaiting additional guidance from 10/23/21 Health Advisory: COVID-19 Updates for Providers

9/17/21 Health Advisory: Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events

blurry waiting room

Summary The purpose of this Health Alert Network (HAN) Health Advisory is to alert public health departments, healthcare professionals, first responders, poison control centers, laboratories, and the public to the increased availability of cannabis products containing delta-8 tetrahydrocannabinol (THC) and the potential for adverse events due to insufficient labeling of products containing THC and cannabidiol 9/17/21 Health Advisory: Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events

8/26/21 Health Advisory: COVID-19 Updates for Providers

stethoscope and heart beat

WCHD Health Alert PROVIDER ALERT – COVID-19 Update August 26th, 2021 Whatcom County Health Department Communicable Disease & Epidemiology Division  Requested Actions Be aware, the U.S. Food and Drug Administration (FDA) granted full authorization to Pfizer-BioNTech COVID-19 vaccine for people 16 years and older. Pfizer-BioNTech will  be marketed as Comirnaty (koe-mir’-na-tee). Pfizer-BioNTech COVID-19 vaccine continues to be available to people 12-15 8/26/21 Health Advisory: COVID-19 Updates for Providers

7/26/21 Health Advisory: Increased Syphilis Transmission Among Heterosexuals

doctor holding up a stethoscope

Requested actions Be aware syphilis transmission is increasing among heterosexuals. Test all pregnant women for syphilis at their first prenatal visit. At 24-28 weeks gestation (early third trimester), re-evaluate for risk factors and test again for syphilis if any exist. Test the following people when they present for care (including at emergency departments): Sexually active 7/26/21 Health Advisory: Increased Syphilis Transmission Among Heterosexuals

7/19/21 Health Advisory: COVID-19 Updates for Providers

Requested actions Be aware the U.S. Food and Drug Administration (FDA) updated the Johnson & Johnson/Janssen (J&J) COVID-19 vaccine Emergency Use Authorization (EUA) fact sheets to include possible risks of thrombosis with thrombocytopenia and Guillain-Barré Syndrome (GBS) following vaccination: Fact sheet for healthcare providers. Fact sheet for patients. Be aware the FDA extended the shelf life of J&J 7/19/21 Health Advisory: COVID-19 Updates for Providers